药康生物(688046)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688046 药康生物

已收盘 05-09 15:00:01

{"stockData":{"symbol":"688046","market":"SH","secType":"STK","nameCN":"药康生物","latestPrice":12.12,"timestamp":1746774001000,"preClose":12.06,"halted":0,"volume":4535270,"delay":0,"changeRate":0.005,"floatShares":409999999,"shares":409999999,"eps":0.2691,"marketStatus":"已收盘","change":0.06,"latestTime":"05-09 15:00:01","open":12,"high":12.23,"low":11.87,"amount":54694700,"amplitude":0.0299,"askPrice":12.12,"askSize":150,"bidPrice":12.11,"bidSize":20,"shortable":0,"etf":0,"ttmEps":0.2691,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1747013400000},"marketStatusCode":5,"adr":0,"adjPreClose":12.06,"symbolType":"stock_kcb","openAndCloseTimeList":[[1746754200000,1746761400000],[1746766800000,1746774000000]],"highLimit":13.27,"lowLimit":10.85,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":410000000,"isCdr":false,"pbRate":2.3,"roa":"--","peRate":45.039019,"roe":"1.4%","epsLYR":0.27,"committee":0.342282,"marketValue":4969000000,"turnoverRate":0.0111,"status":0,"afterMarket":{"amount":0,"volume":0,"close":12.12,"buyVolume":0,"sellVolume":0,"time":1746776038029,"indexStatus":"已收盘 05-09 15:30:00","preClose":12.06},"floatMarketCap":4969000000},"requestUrl":"/m/hq/s/688046","defaultTab":"news","newsList":[{"id":"2533972345","title":"药康生物05月08日主力净流入139.5万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2533972345","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533972345?lang=zh_cn&edition=full","pubTime":"2025-05-08 15:20","pubTimestamp":1746688809,"startTime":"0","endTime":"0","summary":"05月08日, 药康生物股价涨4.33%，报收12.06元，成交金额7921.4万元，换手率1.62%，振幅5.71%，量比1.41。药康生物今日主力资金净流入139.5万元，上一交易日主力净流出512.6万元。该股近5个交易日上涨6.07%，主力资金累计净流出711.9万元；近20日主力资金累计净流入2618.6万元，其中净流入天数为9日。|05月08日主力加仓幅度排名||#|股票简称|主力净额占比|#|*ST双成|8.61%|#|跨境通|7.99%|#|中百集团|7.29%|#|...|...|#1752|药康生物|0.03%|药康生物所在的医疗服务行业，今日主力净流出4968万元，行业排名52/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508170108a4766e6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508170108a4766e6e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688046"],"gpt_icon":0},{"id":"2533394835","title":"药康生物涨5% 公司回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2533394835","media":"智选洞察","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533394835?lang=zh_cn&edition=full","pubTime":"2025-05-08 11:18","pubTimestamp":1746674308,"startTime":"0","endTime":"0","summary":"05月08日，药康生物股价大幅上涨，截至11点18分，药康生物上涨5.19%，报12.16元/股，创近1个月新高，成交4307万元，换手率0.89%，振幅5.62%。主营业务及业绩药康生物公司主营业务为实验动物小鼠模型的研发、生产、销售及相关技术服务。最新财报显示，今年一季报，药康生物实现营业收入1.71亿元，同比增长8.76%，净利润为2,998.03万元，同比增长1.70%，基本每股收益为0.07元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508111849a6d71503&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250508111849a6d71503&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688046"],"gpt_icon":0},{"id":"2533571671","title":"药康生物05月07日遭主力抛售512.6万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533571671","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533571671?lang=zh_cn&edition=full","pubTime":"2025-05-07 15:19","pubTimestamp":1746602399,"startTime":"0","endTime":"0","summary":"05月07日, 药康生物股价跌0.86%，报收11.56元，成交金额6528.4万元，换手率1.37%，振幅3.43%，量比1.11。药康生物今日主力资金净流出512.6万元，连续3日净流出，上一交易日主力净流出335.4万元。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为66.67%，平均跌幅为1.63%。该股近5个交易日上涨2.21%，主力资金累计净流出1131.2万元；近20日主力资金累计净流入1459.0万元，其中净流入天数为8日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507164043a6d61625&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507164043a6d61625&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688046"],"gpt_icon":0},{"id":"2533508718","title":"药康生物：累计回购0.2603%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2533508718","media":"格隆汇","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533508718?lang=zh_cn&edition=full","pubTime":"2025-05-06 16:47","pubTimestamp":1746521223,"startTime":"0","endTime":"0","summary":"格隆汇5月6日丨药康生物(688046.SH)公布，截至2025年4月30日，公司通过上海证券交易所交易系统以集中竞价交易方式累计回购公司股份1,067,387股，占公司总股本的比例为0.2603%，回购成交的最高价为15.13元/股，最低价为10.52元/股，支付的资金总额为人民币13,914,990.75元(不含印花税、交易佣金等交易费用)。【免责声明】本文仅代表作者本人观点，与和讯网无关。和讯网站对文中陈述、观点判断保持中立，不对所包含内容的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考，并请自行承担全部责任。邮箱：news_center@staff.hexun.com","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050616514594edc28a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050616514594edc28a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688046"],"gpt_icon":0},{"id":"2533712905","title":"药康生物：累计回购约107万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2533712905","media":"每日经济新闻","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533712905?lang=zh_cn&edition=full","pubTime":"2025-05-06 16:31","pubTimestamp":1746520262,"startTime":"0","endTime":"0","summary":"每经AI快讯，药康生物（SH 688046，收盘价：11.66元）5月6日晚间发布公告称，截至2025年4月30日，公司通过上海证券交易所交易系统以集中竞价交易方式累计回购公司股份约107万股，占公司总股本4.1亿股的比例为0.2603%，回购成交的最高价为15.13元/股，最低价为10.52元/股，支付的资金总额为人民币约1391万元。截至发稿，药康生物市值为48亿元。每经头条（nbdtoutiao）——巴菲特对美元罕见“警告”后金价重拾升势！投资黄金股看似“避险+增长”双保险，实则暗藏五大真相！(记者 曾健辉)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050616321594edbc6a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050616321594edbc6a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688046"],"gpt_icon":0},{"id":"2531054991","title":"华安证券：给予药康生物买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2531054991","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531054991?lang=zh_cn&edition=full","pubTime":"2025-04-30 23:01","pubTimestamp":1746025277,"startTime":"0","endTime":"0","summary":"华安证券股份有限公司谭国超,杨馥瑗近期对药康生物进行研究并发布了研究报告《利润短期承压，加速推进海外布局》，给予药康生物买入评级。同时2024年公司战略性入股灵康生物，进入实验猪领域，前瞻性布局下一代试验动物模型。维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有4家机构给出评级，买入评级3家，增持评级1家。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025043000048822.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688046","600909"],"gpt_icon":0},{"id":"2531734427","title":"东吴证券：给予药康生物买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2531734427","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531734427?lang=zh_cn&edition=full","pubTime":"2025-04-29 21:19","pubTimestamp":1745932772,"startTime":"0","endTime":"0","summary":"东吴证券股份有限公司朱国广,刘若彤近期对药康生物进行研究并发布了研究报告《2024年报&2025年一季报点评：利润短期承压，海外业务维持高增长》，给予药康生物买入评级。看好公司业务模式及成长空间，维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有3家机构给出评级，买入评级2家，增持评级1家。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042900042472.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601555","688046"],"gpt_icon":0},{"id":"2531271253","title":"药康生物04月29日主力净流入113万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2531271253","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531271253?lang=zh_cn&edition=full","pubTime":"2025-04-29 15:20","pubTimestamp":1745911254,"startTime":"0","endTime":"0","summary":"04月29日, 药康生物股价涨1.06%，报收11.49元，成交金额4213.8万元，换手率0.90%，振幅2.64%，量比0.55。药康生物今日主力资金净流入113万元，上一交易日主力净流出280万元。该股近5个交易日上涨4.45%，主力资金累计净流入1003万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入2444万元，其中净流入天数为9日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429164354a6ccf3de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429164354a6ccf3de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688046","BK0216"],"gpt_icon":0},{"id":"2531808447","title":"药康生物：利润短期承压 海外业务维持高增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2531808447","media":"东吴证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531808447?lang=zh_cn&edition=full","pubTime":"2025-04-29 00:00","pubTimestamp":1745856000,"startTime":"0","endTime":"0","summary":"利润短期承压，海外业务保持高增长：①分业务来看，24FY 商品化小鼠模型销售营收4.0 亿元，功能药效营收1.5 亿元，定制繁育营收0.85 亿元，模型定制营收0.34 亿元。受投融资下行引起的需求不振等因素影响，商品化小鼠模型尤其人源化小鼠增速有所放缓；但随着公司小鼠品系丰富、药效服务体系完善，功能药效业务保持了快速增长。看好公司业务模式及成长空间，维持“买入”评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429200120a46c22c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429200120a46c22c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688046","BK0216"],"gpt_icon":0},{"id":"2531034602","title":"药康生物：海外市场收入同比增长22.5% 国内新设施接近满产","url":"https://stock-news.laohu8.com/highlight/detail?id=2531034602","media":"国信证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531034602?lang=zh_cn&edition=full","pubTime":"2025-04-29 00:00","pubTimestamp":1745856000,"startTime":"0","endTime":"0","summary":"营收稳健增长，利润端短期承压。分季度看，2024Q1/Q2/Q3/Q4 分别实现营收1.57/1.83/1.69/1.77 亿元、归母净利润0.29/0.47/0.22/0.12 亿元。毛/净利率承压，研发费用率改善。2024 全年公司毛利率为62.0%、净利率16.0%；销售费用率15.6%、管理费用率19.3%、研发费用率12.7%、财务费用率-1.7%，期间费用率整体为45.9%。国内新设施接近满产，欧洲产能已进入规划。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429170624a46bd0b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429170624a46bd0b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688046"],"gpt_icon":0},{"id":"2530002921","title":"药康生物2024年净利润1.1亿元，下降30.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530002921","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530002921?lang=zh_cn&edition=full","pubTime":"2025-04-27 11:33","pubTimestamp":1745724806,"startTime":"0","endTime":"0","summary":"4月25日，药康生物公布2024年年报，公司营业收入为6.87亿元，同比上升10.4%；归母净利润为1.1亿元，同比下降30.9%；扣非归母净利润为7574万元，同比下降29.3%；经营现金流净额为9031万元，同比下降22.5%；EPS为0.2679元。截至四季度末，公司总资产25.73亿元，较上年度末下降0.2%；归母净资产为21.35亿元，较上年度末增长0.5%。公司在2024年度报告中提到，经营业务的主要变动集中在以下几个方面。文章来源：财中社药康生物2024年净利润1.1亿元，下降30.9%","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250427114948a468b77c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250427114948a468b77c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688046"],"gpt_icon":0},{"id":"2530992107","title":"药康生物拟每10股派发现金红利1.1元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530992107","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530992107?lang=zh_cn&edition=full","pubTime":"2025-04-27 11:25","pubTimestamp":1745724321,"startTime":"0","endTime":"0","summary":"4月25日，药康生物（688046）发布公告，公司拟向全体股东每10股派发现金红利1.1元（含税），预计总派发金额为4482万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042711261294e45702&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042711261294e45702&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688046","BK0216"],"gpt_icon":0},{"id":"2530561177","title":"药康生物2025年一季报简析：营收净利润同比双双增长，公司应收账款体量较大","url":"https://stock-news.laohu8.com/highlight/detail?id=2530561177","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530561177?lang=zh_cn&edition=full","pubTime":"2025-04-27 06:19","pubTimestamp":1745705986,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期药康生物发布2025年一季报。截至本报告期末，公司营业总收入1.71亿元，同比上升8.76%，归母净利润2998.03万元，同比上升1.7%。本报告期药康生物公司应收账款体量较大，当期应收账款占最新年报归母净利润比达357.51%。本次财报公布的各项数据指标表现尚佳。然而去年的净利率为15.99%，算上全部成本后，公司产品或服务的附加值高。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250427062711a6c9b63a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250427062711a6c9b63a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688046"],"gpt_icon":0},{"id":"2530919142","title":"药康生物3月31日股东户数0.58万户，较上期减少4.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530919142","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530919142?lang=zh_cn&edition=full","pubTime":"2025-04-26 17:08","pubTimestamp":1745658497,"startTime":"0","endTime":"0","summary":"证券之星消息，近日药康生物披露，截至2025年3月31日公司股东户数为5832.0户，较12月31日减少291.0户，减幅为4.75%。在医疗服务行业个股中，药康生物股东户数低于行业平均水平，截至3月31日，医疗服务行业平均股东户数为4.45万户。从股价来看，2024年12月31日至2025年3月31日，药康生物区间涨幅为7.39%，在此期间股东户数减少291.0户，减幅为4.75%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426171714a467e533&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250426171714a467e533&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688046"],"gpt_icon":0},{"id":"2530795166","title":"图解药康生物一季报：第一季度单季净利润同比增1.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530795166","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530795166?lang=zh_cn&edition=full","pubTime":"2025-04-26 02:30","pubTimestamp":1745605825,"startTime":"0","endTime":"0","summary":"证券之星消息，药康生物2025年一季报显示，公司主营收入1.71亿元，同比上升8.76%；归母净利润2998.03万元，同比上升1.7%；扣非净利润2510.89万元，同比上升9.8%；负债率18.45%，投资收益28.96万元，财务费用-228.37万元，毛利率63.05%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由智能算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042600000973.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688046"],"gpt_icon":0},{"id":"2530016880","title":"图解药康生物年报：第四季度单季净利润同比减71.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530016880","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530016880?lang=zh_cn&edition=full","pubTime":"2025-04-26 01:11","pubTimestamp":1745601070,"startTime":"0","endTime":"0","summary":"证券之星消息，药康生物2024年年报显示，公司主营收入6.87亿元，同比上升10.39%；归母净利润1.1亿元，同比下降30.89%；扣非净利润7574.31万元，同比下降29.33%；其中2024年第四季度，公司单季度主营收入1.77亿元，同比上升5.67%；单季度归母净利润1160.54万元，同比下降71.83%；单季度扣非净利润393.28万元，同比下降84.59%；负债率17.02%，投资收益800.38万元，财务费用-1158.28万元，毛利率61.99%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042600000479.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688046"],"gpt_icon":0},{"id":"2530153059","title":"药康生物（688046）2.06亿股限售股将于4月25日解禁，占总股本50.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2530153059","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530153059?lang=zh_cn&edition=full","pubTime":"2025-04-25 08:03","pubTimestamp":1745539392,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，药康生物于4月25日将有2.06亿股限售股份解禁，为公司首发原股东限售股份，占公司总股本50.26%。最近一年内，该股累计解禁200.0万股，占总股本的0.49%。药康生物主营业务：实验动物模型的研发创制、生产销售及相关技术服务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025042500009147.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688046","BK0216"],"gpt_icon":0},{"id":"2530915850","title":"A股限售股解禁一览：91.0亿元市值限售股今日解禁","url":"https://stock-news.laohu8.com/highlight/detail?id=2530915850","media":"每日经济新闻","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530915850?lang=zh_cn&edition=full","pubTime":"2025-04-25 07:49","pubTimestamp":1745538554,"startTime":"0","endTime":"0","summary":"每经AI快讯，Wind数据显示，周五（4月25日），共有8家公司限售股解禁，合计解禁量为5.97亿股，按最新收盘价计算，合计解禁市值为91.0亿元。从解禁量来看，5家公司解禁股数超千万股。药康生物、顾地科技、可孚医疗解禁量居前，解禁股数分别为2.06亿股、1.66亿股、1.04亿股。从解禁市值来看，5家公司解禁股数超亿元。可孚医疗、药康生物、凯尔达解禁市值居前，解禁市值分别为33.91亿元、22.5亿元、12.83亿元。从解禁股数占总股本比例来看，5家公司解禁比例超10%。福莱蒽特、药康生物、可孚医疗解禁比例居前，解禁比例分别为53.29%、50.26%、49.6%。每日经济新闻","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425075137a466032b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425075137a466032b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688046","BK0216","399300","159982"],"gpt_icon":0},{"id":"2529053675","title":"【明日解禁】明日9股解禁 可孚医疗、药康生物解禁市值居前","url":"https://stock-news.laohu8.com/highlight/detail?id=2529053675","media":"东方财富研究中心","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529053675?lang=zh_cn&edition=full","pubTime":"2025-04-24 15:27","pubTimestamp":1745479673,"startTime":"0","endTime":"0","summary":"东方财富Choice数据显示，明日（4月25日）将有9只股票面临解禁，合计解禁量为6.06亿股，合计解禁市值为92.38亿元。从解禁市值看，东方财富Choice数据显示，明日面临解禁的9只股票中，可孚医疗、药康生物、凯尔达居前，解禁市值分别为34.22亿元、22.79亿元、13.35亿元。解禁比例方面，福莱蒽特、药康生物、可孚医疗分别为53.29%、50.26%、49.60%，居于前列。文章来源：东方财富研究中心","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424155934a465005c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250424155934a465005c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["301087","BK0216","BK0251","688046"],"gpt_icon":0},{"id":"2529258955","title":"药康生物04月23日获主力加仓377万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529258955","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529258955?lang=zh_cn&edition=full","pubTime":"2025-04-23 15:20","pubTimestamp":1745392815,"startTime":"0","endTime":"0","summary":"04月23日, 药康生物股价涨0.55%，报收11.06元，成交金额8188万元，换手率3.61%，振幅2.64%，量比1.50。药康生物今日主力资金净流入377万元，上一交易日主力净流入1210万元。该股近5个交易日上涨0.09%，主力资金累计净流入637万元；近20日主力资金累计净流入1611万元，其中净流入天数为7日。|04月23日主力加仓幅度排名||#|股票简称|主力净额占比|#|健尔康|8.43%|#|新天地|7.95%|#|利安科技|7.56%|#|...|...|#729|药康生物|0.17%|药康生物所在的医疗服务行业，今日主力净流出1.22亿元，行业排名41/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423160211a463970b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423160211a463970b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688046","BK0216"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1746801338516,"stockEarnings":[{"period":"1week","weight":0.0598},{"period":"1month","weight":0.0787},{"period":"3month","weight":-0.1355},{"period":"6month","weight":-0.1584},{"period":"1year","weight":-0.0434},{"period":"ytd","weight":-0.0615}],"compareEarnings":[{"period":"1week","weight":0.0223},{"period":"1month","weight":0.0656},{"period":"3month","weight":0.0146},{"period":"6month","weight":-0.0291},{"period":"1year","weight":0.0714},{"period":"ytd","weight":0.0001}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"江苏集萃药康生物科技股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"5832人(较上一季度减少4.75%)","perCapita":"70301股","listingDate":"2022-04-25","address":"江苏省南京市浦口区江北新区学府路12号","registeredCapital":"41000万元","survey":"　　江苏集萃药康生物科技股份有限公司是一家专业从事实验动物小鼠模型的研发、生产、销售及相关技术服务的高新技术企业，主要产品有商品化小鼠模型销售业务、模型定制业务、定制繁育业务、功能药效业务、代理进出口及其他业务。公司为国内模式动物行业龙头企业之一，是亚洲小鼠突变和资源联盟唯一企业成员、国家科技资源共享服务平台（国家遗传工程小鼠资源库）共建单位，先后被认定为国家级高新技术企业、江苏省博士后创新实践基地、江苏省工程技术研究中心、国家级专精特新小巨人企业等。","listedPrice":22.53},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.4","shortVersion":"4.33.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药康生物(688046)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药康生物(688046)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药康生物,688046,药康生物股票,药康生物股票老虎,药康生物股票老虎国际,药康生物行情,药康生物股票行情,药康生物股价,药康生物股市,药康生物股票价格,药康生物股票交易,药康生物股票购买,药康生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药康生物(688046)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药康生物(688046)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}